Michigan HIPEC Oncology Collaborative

[Annals of Surgical Oncology @AnnSurgOncol]

AHEAD OF PRINT: The Landmark Series: #CytoreductiveSurgery and #HyperthermicIntraperitonealChemotherapy (CRS/HIPEC) for Treatment of #GastricCancer Metastatic to Peritoneum. #peritonealmetastases https://t.co/TqRR7n2wsr @McMastersKelly @SocSurgOnc

[Faheez Mohamed @FaheezM]

Pressurized intraperitoneal aerosol chemotherapy in peritoneal carcinomatosis: is it all up in the air? https://t.co/al4EKUrN3h

[UChicagoCancerCenter @UCCancerCenter]

In patients with #gastriccancer (2nd leading cause of cancer-related deaths worldwide), surgery plus systemic #chemotherapy improves overall survival of #metastatic patients vs. chemo alone - as shown by @kturaga in @AnnSurgOncol #AnswerCancer
https://t.co/COQcXlm6ju

[Society of Surgical Oncology @SocSurgOnc]

Join @kturaga, @AGangiMD, Edward A. Levine, MD, Scott K. Sherman, MD, Joel Baumgartner, MD, Maheswari Senthil, MD, and Byrne Lee, MD for a new Peritoneal Surface Malignancies Virtual Tumor Board on Monday. Registration is open now at https://t.co/RWAq5NxXlc.

[European Journal of Surgical Oncology @ejsotweets]

@operarelcancer @Cerrahi_Onko @SOS_Pk @sbco_oficial @DeHugc @BASO_ACS @SICOBoard @escp_tweets @SocSurgOnc @Surgery_TCD @CRS_HIPEC @HipecMichigan @AppendixPMP @ASiTofficial @ACPGBI

[Lana Bijelic @LanaBijelicMD]

1⃣Peritonectomy procedures; Ann Surg 1995 2⃣CYTO-CHIP; J Clin Oncol 37:2028-2040 3⃣DMPM multi-inst;J Clin Oncol 27:6237-62424⃣PMP multi-inst;J Clin Oncol 30:2449-24565⃣Ovarian RCT;N Engl J Med 2018;378:230-406⃣Colon RCT;J Clin Oncol 21(20) 2003

[The Lancet Oncology @TheLancetOncol]

Online first: phase 3 study of second-look #surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs surveillance in patients at high risk of developing colorectal peritoneal metastases—PROPHYLOCHIP–PRODIGE 15 https://t.co/Ejcn41uaRv

[Annals of Surgical Oncology @AnnSurgOncol]

In newly diagnosed #LAMN, peritoneal spread & distribution of cellular mucin negatively affect PFS, but not OS despite optimal treatment with #CompleteCytoreductiveSurgery and #HIPEC. #VisualAbstract. @McMastersKelly @SocSurgOnc https://t.co/slV7ffvURQ

[Lana Bijelic @LanaBijelicMD]

Very interesting 1-year PFS of 54% for refractory and unresectable #peritoneal #mesothelioma. resectable pts have median OS of 42 months in our recent #NCDB analysis of 2000 pts in @AnnSurgOncol and 5-year survival 50% in many #CRS#HIPEC series @InovaHealth

[Rupen Shah @RupenShahMD]

Great talk by @kturaga from @UCCancerCenter regarding the management of peritoneal metastases especially during this pandemic. #Covid_19 #hipec #peritonealmetastases @SocSurgOnc

[Annals of Surgical Oncology @AnnSurgOncol]

JUNE ISSUE: Multidisciplinary recommendations for management of #PeritonealSurfaceMalignancies of #Colorectal origin. #ChicagoConsensusWorkingGroup. #ColorectalCancer #PeritonealMetastasis @kturaga .
@McMastersKelly @SocSurgOnc https://t.co/6bCpqKBbDY

[Annals of Surgical Oncology @AnnSurgOncol]

QoL deteriorates w/in 6mos>cytoreductive surg&HIPEC, returns to baseline by 12mos. Negatively influenced by age, operation times, ext & residual dis, adjCT, complications, stoma plcmnt, recurrence. #VisualAbstract @JordanBaechle @McMastersKelly @SocSurgOnc https://t.co/HjmqLkN8JA

[Annals of Surgical Oncology @AnnSurgOncol]

Routine use of #LactatedRinger’s (LR) carrier solution during #HIPEC to reduce intraoperative #hyperglycemia and associated risks. #VisualAbstract. @CUSurgOnc @McMastersKelly @SocSurgOnc https://t.co/IFwveliBe6

[Delia Cortés Guiral @DeliaCortesGuir]

Extremely relevant paper regarding safety during covid patients surgery: SARS-CoV-2 is present in peritoneal fluis in COVID-19 patients https://t.co/OQBtj4qtnN @SWexner @juliomayol @ManishChandSurg @venky72 @dr_samehhany81 @vincentobiasMD @MarkarSheraz @me4_so @AnnalsofSurgery

[Annals of Surgical Oncology @AnnSurgOncol]

MAY ISSUE: Surgery with Radical Intent: Is There an Indication for G3 #NeuroendocrineNeoplasms? #endocrinetumors https://t.co/9ePmQl4CK4 @McMastersKelly @SocSurgOnc

[European Journal of Surgical Oncology @ejsotweets]

🔓OPEN ACESS🔓

Periop safety after CRS + HIPEC for PMP from appendiceal origin: Experience on 254 patients from a single 🇨🇳 center

https://t.co/SMul1GYaoH

@ESSOnews @SPeritoneum @DeliaCortesGuir @acpmpresearch @AGangiMD @D_JafariMD @PeritonealCaDoc @RupenShahMD @FabianJohnston

[ACS Journal Cancer @JournalCancer]

Multidisciplinary recommendations for the management of peritoneal #mesothelioma as provided by the Chicago Consensus Working Group: https://t.co/2coZ5Nbzrs @kturaga @AlejandroPlana @UCCancerCenter

[ACS Journal Cancer @JournalCancer]

We are pleased to publish in partnership with @AnnSurgOncol a series examining the Chicago Consensus Guidelines for Peritoneal Surface Malignancies. Read an introduction from lead organizer @kturaga: https://t.co/624E1NSPII @UCCancerCenter

[Annals of Surgical Oncology @AnnSurgOncol]

AHEAD OF PRINT: Extent of #PeritonealMetastases on Preoperative DW-MRI is Predictive of Disease-Free and Overall Survival for CRS/HIPEC Candidates with #ColorectalCancer. https://t.co/93ULxJ8oAn @McMastersKelly @SocSurgOnc

[Delia Cortés Guiral @DeliaCortesGuir]

This is a very imp paper.PSOGI consensus on #appendix neoplasm and #pseudomyxoma peritonei finally published!!!! https://t.co/hNrkLjVrFQ @SPeritoneum @Cirbosque @gecop @operarelcancer @SPeritoneum @SWexner @marianaberho @AndreasBrandl8 @alarjosan @dr_mohammadyami @oliviawriting